Trial Profile
Investigation of the clinical safety and efficacy of favipiravir (Avigan tablets) in patients with novel or re-emerging influenza virus infections
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Oct 2018
Price :
$35
*
At a glance
- Drugs Favipiravir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors FUJIFILM Toyama Chemical; Toyama Chemical
- 28 Mar 2018 New trial record